Crossmark

RETRACTED ARTICLE: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

Crossref DOI link: https://doi.org/10.1186/s40478-016-0410-8

Published Online: 2017-01-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Spencer, Brian

Valera, Elvira

Rockenstein, Edward

Overk, Cassia

Mante, Michael

Adame, Anthony

Zago, Wagner

Seubert, Peter

Barbour, Robin

Schenk, Dale

Games, Dora

Rissman, Robert A.

Masliah, Eliezer
Funding

Funding for this research was provided by:

National Institutes of Health (AG010483)

National Institutes of Health (AG005131)

Prothena Biosciences Inc
License Information

Text and Data Mining valid from 2017-01-13

Version of Record valid from 2017-01-13
More Information

Article History

Received: 29 October 2016

Accepted: 20 December 2016

First Online: 13 January 2017

Change Date: 26 March 2026

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1186/s40478-026-02279-x

Retraction Retraction dated 2026-03-26

Click to view Retraction: https://doi.org/10.1186/s40478-026-02279-x